Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
Tysabri
mfERG_LAB: Software for processing multifocal electroretinography signals.
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
Progressive multiple sclerosis: The treatment gap.
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.
Symptom overlap in anxiety and multiple sclerosis.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
Pages
« first
‹ previous
…
155
156
157
158
159
160
161
162
163
…
next ›
last »